Treace Medical Concepts, Inc.
TMCI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $426 | $370 | $526 | $464 |
| - Cash | $8 | $8 | $13 | $11 |
| + Debt | $13 | $70 | $69 | $70 |
| Enterprise Value | $431 | $433 | $582 | $522 |
| Revenue | $50 | $47 | $53 | $69 |
| % Growth | 6% | -9.9% | -23.5% | – |
| Gross Profit | $40 | $38 | $42 | $55 |
| % Margin | 79.1% | 79.7% | 79.7% | 80.7% |
| EBITDA | -$12 | -$14 | -$12 | $3 |
| % Margin | -24.2% | -28.5% | -23.1% | 4.4% |
| Net Income | -$16 | -$17 | -$16 | -$1 |
| % Margin | -32.4% | -36.7% | -30.3% | -0.7% |
| EPS Diluted | -0.26 | -0.28 | -0.25 | -0.008 |
| % Growth | 7.1% | -12% | -3,025% | – |
| Operating Cash Flow | -$9 | -$3 | $4 | -$4 |
| Capital Expenditures | -$3 | -$5 | -$4 | -$3 |
| Free Cash Flow | -$12 | -$8 | $1 | -$7 |